ID   ML5
AC   CVCL_D278
SY   ML-5
DR   BTO; BTO_0004040
DR   Wikidata; Q54905942
RX   PubMed=9441775;
RX   PubMed=9554442;
CC   Doubling time: 1.9 +- 0.2 days (PubMed=9441775).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C4511; Ovarian serous cystadenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
RX   PubMed=9441775; DOI=10.1006/gyno.1997.4880;
RA   Luo M.P., Gomperts B.N., Imren S., DeClerck Y.A., Ito M., Velicescu M.,
RA   Felix J.C., Dubeau L.;
RT   "Establishment of long-term in vitro cultures of human ovarian
RT   cystadenomas and LMP tumors and examination of their spectrum of
RT   expression of matrix-degrading proteinases.";
RL   Gynecol. Oncol. 67:277-284(1997).
//
RX   PubMed=9554442; DOI=10.1093/jnci/90.8.597;
RA   Sabichi A.L., Hendricks D.T., Bober M.A., Birrer M.J.;
RT   "Retinoic acid receptor beta expression and growth inhibition of
RT   gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl)
RT   retinamide.";
RL   J. Natl. Cancer Inst. 90:597-605(1998).
//